Literature DB >> 9820527

Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma antibodies alters trypanosome-susceptible mice to a resistant-like phenotype.

J E Uzonna1, R S Kaushik, J R Gordon, H Tabel.   

Abstract

The mechanisms regulating resistance or susceptibility to African trypanosomes have been enigmatic. In this study, we assessed the production of several cytokines (IL-4, IFN-gamma, and TNF-alpha) in vivo and in vitro using genetically susceptible (BALB/c) or resistant (C57BL/6) mice infected with cloned Trypanosoma congolense and the role of these cytokines in pathogenesis of this infection. Plasma of infected BALB/c mice contained higher levels of IL-4 and IFN-gamma than the plasma of infected C57BL/6 mice. Conversely, plasma TNF-alpha levels were elevated significantly in the resistant mice relative to the susceptible ones. Splenic IFN-gamma mRNA appeared earlier and were maintained at higher levels in infected BALB/c than in C57BL/6 mice. Both spontaneous and Con A-induced secretions of IL-4 and IFN-gamma by splenocytes from infected BALB/c mice were significantly higher than those from their C57BL/6 counterparts. Con A-induced proliferation of splenocytes from infected BALB/c mice was progressively suppressed. Nitric oxide was not involved in this suppression, but the suppression was positively correlated with IFN-gamma secretion. Addition of neutralizing Abs to IFN-gamma to cultures of Con A-stimulated spleen cells from infected BALB/c mice effectively reversed this suppression. Furthermore, administration of anti-IFN-gamma Abs to BALB/c mice early during infection dramatically shifted the phenotype of these susceptible mice to a more resistant-like phenotype, as expressed by a low and undulating parasitemia and a >300% increase in survival period. These results strongly suggest that the enhanced induction and secretion of IFN-gamma during T. congolense infections contribute to the relative susceptibility of BALB/c mice to the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820527

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Impaired Kupffer cells in highly susceptible mice infected with Trypanosoma congolense.

Authors:  Meiqing Shi; Guojian Wei; Wanling Pan; Henry Tabel
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice.

Authors:  Wim Noël; Gholamreza Hassanzadeh; Geert Raes; Boniface Namangala; Inge Daems; Lea Brys; Frank Brombacher; Patrick De Baetselier; Alain Beschin
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  Anti-gamma interferon antibodies enhance the immunogenicity of recombinant adenovirus vectors.

Authors:  Shawn S Jackson; Jörn E Schmitz; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

4.  Interleukin-17-mediated control of parasitemia in experimental Trypanosoma congolense infection in mice.

Authors:  Zhirong Mou; Ping Jia; Shiby Kuriakose; Forough Khadem; Jude E Uzonna
Journal:  Infect Immun       Date:  2010-09-20       Impact factor: 3.441

5.  Distinct Contributions of CD4+ and CD8+ T Cells to Pathogenesis of Trypanosoma brucei Infection in the Context of Gamma Interferon and Interleukin-10.

Authors:  Gongguan Liu; Donglei Sun; Hui Wu; Mingshun Zhang; Haixia Huan; Jinjun Xu; Xiquan Zhang; Hong Zhou; Meiqing Shi
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

6.  Re-evaluating natural resistance to herpes simplex virus type 1.

Authors:  William P Halford; John W Balliet; Bryan M Gebhardt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrier.

Authors:  Willias Masocha; Brita Robertson; Martin E Rottenberg; Jama Mhlanga; Lydia Sorokin; Krister Kristensson
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

8.  Low-dose intradermal infection with trypanosoma congolense leads to expansion of regulatory T cells and enhanced susceptibility to reinfection.

Authors:  Chukwunonso Onyilagha; Ifeoma Okwor; Shiby Kuriakose; Rani Singh; Jude Uzonna
Journal:  Infect Immun       Date:  2013-12-16       Impact factor: 3.441

9.  Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasis.

Authors:  Marcelo Sousa Silva; Duarte Miguel F Prazeres; Andreia Lança; Jorge Atouguia; Gabriel Amaro Monteiro
Journal:  Parasitol Res       Date:  2009-07-07       Impact factor: 2.289

10.  Diminazene aceturate (Berenil) modulates the host cellular and inflammatory responses to Trypanosoma congolense infection.

Authors:  Shiby Kuriakose; Helen M Muleme; Chukwunonso Onyilagha; Rani Singh; Ping Jia; Jude E Uzonna
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.